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A Broad Perspective on Biotechnology 
and Environmental Regulation 
GLENN L. RADDE 
Glenn L. Radde is a Senior State Planner in the Office of Planning at the Department of Natural Resources. 
I think that it is of the utmost importance to keep the 
political and scientific sides of biotechnology well balanced 
within the realm of public policy. There are at least two 
discernible groupings of people regarding biotechnology. 
There are those who sing its praises and those who ponder 
how little we really know of basic life processes. 
In the public policy arena, government is often caught in a 
netherworld between promises and realities-where it is 
often difficult to find truly honest, impartial advisors. While 
the public expects the government to act on everyone's 
behalf, interest groups representing the "public" get espe-
cially upset when they are slighted. For example, it is hard for 
anyone to deny a company help that is willing to invest large 
amounts of money in economically depressed areas. It is 
equally hard for an elected official to ignore companies who 
create more jobs than the typical margin of victory in local 
elections. 
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Very briefly, environmental regulation in the biotechnology 
area stems from the efforts in the 1970s of various federal 
agencies (e.g., National Institutes of Health (NIH), National 
Science Foundation (NSF), Environmental Protection Agency 
( EPA). In December, 1984, the White House Office of Science 
and Technology published in the Federal Register a "Proposal 
for a Coordinated Framework for Regulation of Biotechnol-
ogy" to standardize and harmonize the federal agencies' regu-
latory posture (1 ) . 
Within this document, the EPA, Food and Drug Administra-
tion (FDA), and U.S. Department of Agriculture (USDA) pub-
lished statements of policy defining the areas of biotechnol-
ogywith which they would be most concerned. FDA was to be 
concerned only if undesirable foreign materials are intro-
duced into pharmaceutical or food preparations. USDA saw no 
difference between recombinant DNA-derived plants and tra-
ditional crossbred variants. Finally, EPA considered its role to 
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be prevention (not abatement), under the Toxic Substances 
Control Act (TSCA) and the Federal Insecticide, Fungicide, 
and Rodenticide Act (FIFRA). 
As soon as the "coordinated framework" was out, it was 
attacked by representatives of some companies as too restric-
tive, and by environmentalists as too lax. The federal agencies 
continued to actively seek out a middle ground on which they 
could do their work while balancing their public and envir-
onmental protection mandates under various federal laws. On 
June 26, 1986, the Federal Register printed an updated "coor-
dinated framework" (2, 3). This report laid out the domain of 
responsibility for federal agencies based on the existing sta-
tutes, which provide a basic framework for agency jurisdiction 
over research and production. The responsibility for a single 
product is to be with a single agency, with assistance from 
others if needed. For example, FDA is to oversee foods/ food 
additives, human drugs, medical devices and biologics, and 
animal drugs. Animal Protection Health Inspection Service 
(APHIS) reviews animal biologics. EPA and APHIS will review 
all microorganisms to be released into the environment. A 
similar framework is proposed for research work; in this area 
review is mandatory for federally funded work, and voluntary 
for nonfederally funded work 
There are several intriguing problems, all too briefly 
addressed in the 1986 framework For example, what is a 
"release"? Containment is often thought of as strict control 
within a laboratory environment. Yet, according to the 1986 
framework, containment can also be "biologic" when an 
organism's reproductive ability can be curtailed, if not elimi-
nated. "Releases" then involve complexities of physical and 
biological limitations .. 
Genetically engineered microorganism types are dicho-
tomized as well in the 1986 framework EPA has decided that 
inter-organic (i.e., combinations from source organisms of 
different genera), not intra-generic combinations (source 
organisms from same genera), are the most likely to result in 
new combinations of traits. It is this type of organism that will 
merit special regulatory attention. But, inter-generic orga-
nisms can be excluded from regulation if the added genetic 
material consists on(yofwell-characterized, noncoding regu-
latory regions. These organisms, they think, will not exhibit 
new traits, but only quantitative changes in preexisting traits. 
If it is not clear yet, environmental regulation is, as William 
Ruckelshaus once said, a "shotgun wedding between science 
and law" ( 4). Commonly, most regulation is of the "command 
and control" type. We list proscribed behaviors, and fine/ in-
carcerate violators. There is some talk, and experience, with a 
"reward" based system of regulation that provides tax incen-
tives, grants, etc. to responsible firms. Yet both of these types 
depend upon some assessment of liability and risk With 
regard to biotechnology, the advice regarding risk has been 
mixed. For example, Martin Alexander, a microbial ecologist, 
( 5) saw the ultimate risk of a genetically engineered organism 
as a function of six independent probabilities, i.e., probabili-
ties derived from the answers to these questions: 
1. Will the organism be released? 
2. Will it survive in the natural environment? 
3. Will it reproduce? 
4. Will its genetic information travel to other organisms? 
5. Will it disperse? 
6. Will it be harmful? 
In my opinion, only the last question is of use to a regulatory 
agency, and of course, it is the most vague. In fact, 1984 
hearings of the House Subcommittee of Investigations and 
Oversight and the Committee on Science, Research, and 
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Technology ended by saying that there is a small chance of a 
"high consequence risk" ( 6, 7). In other words, almost every-
one seems to agree that there is a very, very slim chance of a 
released organism going completely bonkers. Yet, all agree 
that when it does happen, it is going to be incredibly severe. 
What are the problems and opportunities that face us? First, 
we lack an adequate base in predictive ecology. We cannot 
expect that to be developed by the state agencies. This help 
must come from the universities and from the federal agen-
cies. Second, the current case-by-case review procedure is 
only an interim phase; scale-up is coming. It is when we start 
spreading otherwise innocuous organisms across millions of 
acres that we can really determine the ecological effects. 
Geographers learn that human alteration is pervasive in North 
America. If the Europeans did not alter an area, the Native 
Americans surely did. We are now entering a whole new era of 
landscape alterations. For example, will the distribution of 
"weed" species significantly change from the ice-minus bac-
teria? 
Minnesota has a strong environmental policy law on the 
books-laws 1973, chapter412, 116D (8, 9). Its purpose is to 
"(a) declare a state policy that will encourage productive and 
enjoyable harmony between human beings and their envir-
onment; (b) to promote efforts that will prevent or eliminate 
damage to the environment and biosphere and stimulate the 
health and welfare of human beings; and (c) to enrich the 
understanding of the ecological systems and natural resources 
important to the state and to the nation." 
Minnesota, like most other states, has no specific regulatory 
authority regarding biotechnology. But, I think it would be a 
fairly easy legislative change to grant an agency authority to 
actively explore this issue with the federal agencies. Wiscon-
sin is the best model we have in this situation. 
What can be a positive impact of all this? Since 1977, Cam-
bridge, Mass. , has had a strong biotechnology ordinance. Two 
things have resulted. First, public health safety issues were 
pushed to a state-of-the-art discussion. Second, informed con-
sent became the standard operating procedure for the 
community-elected officials are fully informed of what is 
going on within a company. I think this is where the future of 
regulation will be. 
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CALENDAR OF EVENTS 
Editor's note: This calendar is intended to inform MAS members and others about scientzfic meetings and symposia of interest 
in Minnesota and surrounding states. Please send notices of upcoming events to The Editor, Minnesota Academy of Science 
journal, Suite 916 Pioneer Building, St. Paul, MN 55101. 
November 
22-24: 20th Annual North Central Junior 
Science, Engineering, and Humanities 
Symposium. Kahler Hotel , Rochester, 
MN. Nancy Zwickey, Lake Crystal High, 
director. 
March 
3-5: International Symposium: Man-
Health-Environment. Luxemburg. In con-
junction with the Departments for Envir-
onment and Health of Luxemburg, and, 
on the occasion ofthe European Year of 
the Environment, the International 
Society for Research on Civilization Dis-
eases and Environment organizes an 
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International Symposium on the topic: 
Man-Health-Environment. For informa-
tion about registration, submission of 
posters, and travel arrangements contact: 
Secretariat Annee Europeenne de !'En-
vironment, c/ o Ministere de !'Environ-
ment, 5a rue de Prague, L-2341 Luxem-
bourg. Phone: (352 48 8007), Telefax 400 
410, Telex: 2536 MINENV-LU 
April 
17-19: 51st Annual State Science Fair and 
Research Paper Program. Mankato State 
University. Wayne Anderson, St. Clair 
High, director. 
29-30: Minnesota Academy of Science 
56th Annual Spring Meeting. Macalester 
College, St. Paul, MN. Wayland Ezell , St. 
Cloud State University, program chair. 
Elizabeth Hobbs and Mark Davis, local 
co-chairs. 
August 
7-11: 11th North American Prairie Con-
ference , Prairie Pioneers: Ecology, His-
tory and Culture. Lincoln, NE: For more 
information write: 1988 N.A. Prairie Con-
ference, Department of Biology, Univer-
sity of Nebraska at Omaha, Omaha, NE 
68182-0040. 
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